REVIVE-HF:沉浸式虚拟现实联合运动康复用于住院心力衰竭患者的随机对照试验方案
REVIVE-HF是一项随机、对照、平行组、1:1分配的试验方案,拟纳入确诊心力衰竭的成年住院患者,比较单纯功率自行车有氧运动与联合Meta Quest 2虚拟现实设备的相同运动。每名参与者完成单次最长20分钟的运动,由5个3分钟连续蹬车组块与1分钟被动休息交替组成,不耐受时提前终止。主要结局为因体力限制或症状中断前的有效运动时间(分钟)。
要点
- 拟纳入心力衰竭住院患者,1:1随机分为单纯功率自行车有氧运动组与联合VR设备组。
- 每名参与者完成单次最长20分钟运动,含5个3分钟蹬车组块及1分钟被动休息。
- 主要结局为因体力限制或症状中断前的有效运动时间(分钟)。
核心结论
- 本研究将探讨VR能否改善心力衰竭住院期间对有氧运动的耐受性,可能为沉浸式技术在心脏康复中的应用提供初步证据。
- 若观察到获益,VR可作为补充工具,用于优化该临床情境下监督运动项目的依从性、动机和安全性。
研究设计与样本
- 随机、对照、平行组试验,1:1分配。
- 研究对象为确诊心力衰竭的成年住院患者,筛选合格后随机分入对照组(功率自行车有氧运动)和干预组(相同运动联合Meta Quest 2 VR设备)。
- 每名参与者完成单次最长20分钟的运动,由5个3分钟连续蹬车组块与1分钟被动休息交替组成,不耐受时提前终止。
主要发现
- 主要结局为因体力限制或症状中断前的有效运动时间(分钟)。
- 次要结局包括自觉用力程度评分、血流动力学参数、运动愉悦感(PACES)和技术可用性(SUS,仅干预组)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heart failure (HF) is a chronic condition characterized by significant functional limitations, with exercise intolerance as a major determinant of reduced quality of life. Supervised aerobic exercise is a core intervention in cardiac rehabilitation, yet adherence and tolerance may be hindered by physical and motivational factors. Immersive technologies such as virtual reality (VR) have shown potential to increase engagement and positive perceptions during exercise. This study aims to evaluate the influence of VR on tolerance to cycle-ergometer aerobic exercise in hospitalized patients with HF. METHODS: We will conduct a randomized, controlled, parallel-group trial with 1:1 allocation. Adult inpatients with a diagnosis of HF will be screened for eligibility and randomly assigned to two groups: control (cycle-ergometer aerobic exercise) and intervention (the same exercise combined with an Meta Quest 2 VR device). Each participant will complete a single session of up to 20 min, consisting of five blocks of 3 min of continuous pedaling interspersed with one-minute passive rests, with early termination in case of intolerance. The primary outcome is effective exercise time (minutes) until interruption due to physical limitation or symptoms. Secondary outcomes include rating of perceived exertion, hemodynamic parameters, exercise enjoyment (PACES) and usability of the technology (SUS, intervention group only). DISCUSSION: This study will investigate whether VR can improve tolerance to aerobic exercise during hospitalization for HF, potentially providing preliminary evidence to guide the use of immersive technologies in cardiac rehabilitation. If benefits are observed, VR could be incorporated as a complementary tool to optimize adherence, motivation and safety in supervised exercise programs in this clinical context. TRIAL REGISTRATION: The trial was registered in the Brazilian Clinical Trials Registry (ReBEC), under the identifier RBR-4hrmkzz, on March 11, 2022.
引用
- Dos Santos Costa A, Barbosa CB, Guizilini S, et al. REVIVE-HF: rehabilitation with immersive virtual reality and exercise in hospitalized patients with heart failure-a randomized controlled trial protocol. Trials. 2026. PMID: 41593778. doi:10.1186/s13063-026-09430-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。